Correlation of transarterial transport of various dextrans with their physicochemical properties

Biomaterials

Volumn 21, Issue 22, 2000, Pages 2263-2272

  Elmalak, Omar ^a   Lovich, Mark A ^a   Edelman, Elazer ^b  

^a HARVARD UNIVERSITY   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Dextran; Diffusion; Pharmacokinetics; Transarterial transport; Two compartment model; Vascular permeability

Indexed keywords

BLOOD VESSELS; CONTROLLED DRUG DELIVERY; CORRELATION METHODS; DIFFUSION; HYDROGELS; MATHEMATICAL MODELS; MECHANICAL PERMEABILITY; MOLECULAR WEIGHT; PHARMACOKINETICS; TISSUE;

DEXTRAN;

POLYSACCHARIDES;

BIOMATERIAL; DEXTRAN; VASOACTIVE AGENT;

ANIMAL TISSUE; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROSCLEROSIS; BIOPROSTHESIS; BLOOD VESSEL PERMEABILITY; CORRELATION FUNCTION; DRUG DELIVERY SYSTEM; NONHUMAN; PRIORITY JOURNAL; RAT; SURFACE PROPERTY; TARGET ORGAN;

ANIMALS; BIOCOMPATIBLE MATERIALS; CAROTID ARTERIES; DEXTRAN SULFATE; DEXTRANS; DRUG CARRIERS; ENDOTHELIUM, VASCULAR; IODINE RADIOISOTOPES; MATHEMATICS; METABOLIC CLEARANCE RATE; MODELS, BIOLOGICAL; MOLECULAR WEIGHT; RATS; RATS, SPRAGUE-DAWLEY; STRUCTURE-ACTIVITY RELATIONSHIP;

ANIMALIA;

EID: 0034670179     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0142-9612(00)00152-6     Document Type: Article

References (37)

1. Ip J.H., Fuster V., Badimon L., Badimon J., Taubman M.B., Chesebro J.H. Syndromes of accelerated atherosclerosis. role of vascular injury and smooth muscle proliferation J Am Coll Cardiol. 15:1990;1667-1687.
2. Lidner V, Majack RA, Reidy MA. Basic fibroblast growth factor stimulates endothelial regrowth and proliferation in denuded arteries 1990;85:2004-8.
3. Edelman E.R., Adams D.A., Karnovsky M.J. Effect of controlled adventitial heparin delivery on smooth muscle cell proliferation following endothelial injury. Proc Natl Acad Sci USA. 87:1990;3773-3777.
4. Okada T., Bark D.H., Mayberg M.R. Local anticoagulation without systemic effect using a polymer heparin delivery system. Stroke. 19:1988;1470-1476.
5. Lambert T., Dev V., Rechavia E., Forrester J.S., Litvack F., Eigler N.L. Localized arterial wall drug delivery from a polymer-coated removable metallic stent. Kinetics, distribution, and bioactivity of forskolin. Circulation. 90:1994;1003-1011.
6. Villa A., Guzman L., Chen W., Golomb G., Levy R., Topol E. Local delivery of dexamethasone for prevention of neointimal proliferation in a rat model of balloon angioplasty. J Clin Invest. 93:1994;1243-1249.
7. Rogers C., Karnovsky M.J., Edelman E.R. Inhibition of experimental neointimal hyperplasia and thrombosis depends on the type of vascular injury and the site of drug administration. Circulation. 88:1993;1215-1221.
8. Hill-West J.L., Chowdhury S.M., Slepian M.J., Hubbell J.A. Inhibition of thrombosis and intimal thickening by in situ photopolymerization of thin hydrogel barriers. Proc Nat Acad Sci. 91:1994;5967-5971.
9. Slepian MJ, Campbell PK, Berrigan K, Roth L, Massia SP, Wesselcouch E, Ron E, Mathiowitz E, Jacob J, Chickering D, Philbrook M. Biodegradable endoluminal polymer layers provide sustained transmural heparin delivery to the arterial wall in vivo. Circulation 1994;90(abstract):I-20.
10. Slepian MJ. Polymeric endoluminal paving: evolving therapeutic methods extending the spectrum of local endovascular interventions. In: Liermann D, editor. Stents: state of the art and future developments. Morin Heights, Canada: Polyscience Publications Inc., 1995. p. 339-55.
11. Lovich M.A., Philbrook M., Sawyer S., Weselcouch E., Edelman E.R. Arterial heparin deposition. role of diffusion convection, and extravascular space Am J Physiol. 275:1998;H2236-H2242.
12. Edelman E.R., Nugent M.A., Karnovsky M.J. Perivascular and intravenous bFGF administration: vascular and solid organ deposition. Proc Nat Acad Sci USA. 30:1993;1513-1517.
13. Edelman E.R., Lovich M.A. Drug delivery models transported to a new level. Nature Biotechnol. 16:1998;146-147.
14. Bratzler R.L., Chisolm G.M., Colton C.K., Smith K.A., Zilversmit D.B., Lees R.S. The distribution of labeled low-density lipoproteins across the rabbit thoracic aorta in vivo. Atherosclerosis. 28:1977;289-307.
15. Duncan L.E., Buck K., Lynch A. Lipoprotein movement through canine aortic wall. Science. 142:1963;972-973.
16. Fry D.L., Cornhill J.F., Sharma H., Pap J.M., Mitschelen J. Uptake of low density lipoprotein, albumin, and water by deendothelialized in vitro minipig aorta. Arteriosclerosis. 6:1986;475-490.
17. Scott P.J., Hurley P.J. The distribution of radio-iodinated serum albumin and low-density lipoprotein in tissues and the arterial wall. Arteriosclerosis. 11:1971;77-103.
18. 125I ]albumin into mildly and severely atheromatous rabbit aortas Arteriosclerosis. 11:1970;119-124.
19. Caro C.G., Ebel W., Laver-Rudich Z., Liron N., Meyer F. Steady albumin transport in the rabbit common caraotid artery. Arteriosclerosis. 289:1979;497-511.
20. Bratzler R.L., Chisolm G.M., Colton C.K., Smith K.A., Zilversmit D.B., Lees R.S. The distribution of labeled albumin across the rabbit thoracic aorta in vivo. Circ Res. 40:1977;182-190.
21. 125I -albumin transport Am J Physiol. 245:1983;H977-H991.
22. Lee M.K., Lander A.D. Analysis of affinity and structural selectivity in the binding of proteins to glycosaminoglycans. development of a sensitive electrophoretic approach Proc Natl Acad Sci USA. 88:1991;2768-2772.
23. San Antonio J.D., Slover J., Lawler J., Karnovsky M.J., Lander A.D. Specificity in the interactions of extracellular matrix proteins with subpopulations of the glycosaminoglycan heparin. Biochemistry. 32:1993;4746-4755.
24. Ricketts C. A synthetic analogue of heparin. Biochem J. 51:1952;129-133.
25. Bernstein A., Hurwitz E., Maron R., Arnon R., Sela M., Wilchek M. Higher antitumor efficacy of daunomycin when linked to dextran. in vivo and in vitro studies J Natl Cancer Inst. 60:1978;379-384.
26. Zhao H., Heindel N.D. Determination of degree of substitution of formyl groups in polyaldehyde dextran by the hydroxylamine hydrochloride method. Pharm Res. 8:1991;400-402.
27. Fingerle J., Au Y.P.T., Clowes A.W., Reidy M.A. Intimal lesion formation in rat carotid arteries after endothelial denudation in absence of medial injury. Arteriosclerosis. 10:1990;1082-1087.
28. Lovich M.A., Edelman E.R. Mechanisms of transmural heparin transport in the rat abdominal aorta after local vascular delivery. Circ Res. 77:1995;1143-1150.
29. Greenblatt D.J., Kock-Weser J. Drug therapy. Clinical Pharmackinetics (first of two parts). N Engl J Med. 293:1975;702-705.
30. Lovich M.A., Edelman E.R. Computational simulations of local vascular heparin deposition and distribution. Am J Physiol. 271:1996;H2014-H2024.
31. Johnson E.M., Berk D.A., Jain R.K., Deen W.M. Diffusion and partitioning of proteins in charged agarose gels. Biophys J. 68:1995;1561-1568.
32. Jain R.K. Transport of Macromolecules in tumor microcirculation. Biotechnol Prog. 1:1985;81-94.
33. Deen W.M., Bohrer M.P., Brenner B.M. Macromolecular transport across the glomerular capillaries. application of pore theory Kidney Int. 16:1979;353-365.
34. Deen WM, Satvat B, Jameieson JM. Theoretical model for glomerular filtration of charged solutes. 1980; 238:F126-39.
35. Hashida M., Kato A., Takakura Y., Sezaki H. Disposition and pharmacokinetics of a polymeric prodrug of mitomycin C, mitomycin C-dextran conjugate, in the rat. Drug Metab Dispos. 12:1984;492-499.
36. Chang R.L.S., Deen W.M., Robertson C.R., Brenner B.M. Permselectivity of the glomerular capillary wall. III. Restricted transport of polyanions. Kidney Int. 8:1975;212-218.
37. Chang R.L.S., Ueki I.F., Troy J.L., Deen W.M., Robertson C.R., Brenner B.M. Permselectivity of the glomerular capillary wall to macromolecules II Experimental observations in the rat. Biophys J. 15:1975;887-906.